Wuhan Kindstar Diagnostics Raises $11 Million in Series B Funding

Wuhan Kindstar Diagnostics, a company that provides esoteric laboratory testing services to China hospitals, raised $11 million in a Series B round. Established in 2003, Kindstar’s network covers 2000 hospitals in 300 China cities, including 660 tertiary care hospitals. The company, which has labs in Beijing, Shanghai and Wuhan, offers 750 advanced diagnostic tests in areas that include hematology, oncology, genetics, infectious diseases, and cardiovascular disease. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});